Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cytely is a Swedish deep-tech startup that provides an AI-driven "Smart Microscopy" platform designed to transform traditional laboratory microscopes into real-time data engines. Founded in 2023 and based in Lund, the company's hardware-agnostic software automates image acquisition and analysis, allowing researchers to quantify complex cellular phenomena with significantly higher speed and statistical robustness. By eliminating manual bottlenecks, Cytely enables labs to generate publication-ready results in minutes rather than months, supporting applications in virology, oncology, and drug discovery. The platform is already utilized by leading research institutions and has demonstrated the ability to replace expensive high-throughput imaging systems with existing laboratory hardware.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Smart Microscopy.